Sign in
4

Changes in Ownership

PharmaCyte Biotech, Inc. Filed Acc 0001683168-26-002633

Options or other derivatives

  • Director acquired 119,170 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
WEINSTEIN ROBERT Director 2026-03-31 Grant or award · Stock Option (Right to Buy) +119,170 119,170 D: show line 1 in the form
Loading xslF345X06/ownership.xml…